1. Home
  2. ONMD vs TIL Comparison

ONMD vs TIL Comparison

Compare ONMD & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneMedNet Corp

ONMD

OneMedNet Corp

HOLD

Current Price

$0.88

Market Cap

56.0M

Sector

N/A

ML Signal

HOLD

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

HOLD

Current Price

$8.06

Market Cap

54.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONMD
TIL
Founded
2006
2018
Country
United States
United States
Employees
23
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.0M
54.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ONMD
TIL
Price
$0.88
$8.06
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$125.00
AVG Volume (30 Days)
836.4K
18.2K
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
6.06
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.31
$5.67
52 Week High
$4.22
$42.75

Technical Indicators

Market Signals
Indicator
ONMD
TIL
Relative Strength Index (RSI) 44.49 46.95
Support Level $0.77 $7.59
Resistance Level $0.97 $8.30
Average True Range (ATR) 0.09 0.30
MACD -0.02 0.01
Stochastic Oscillator 15.91 61.36

Price Performance

Historical Comparison
ONMD
TIL

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Share on Social Networks: